View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

ONWARD® Medical annonce ses résultats financiers et opérationnels pour...

ONWARD® Medical annonce ses résultats financiers et opérationnels pour l’exercice 2023 et partage les faits qui ont marqué l’exercice 2024 à ce jour Dépôt auprès de la FDA d’une demande de classification du dispositif ARC-EX® System basée sur les risques (demande « De Novo ») Levée de fonds de 20 millions d’euros Annonce des résultats préliminaires positifs de l’étude pivot Up-LIFT Mise en place d’un partenariat visant à accéder rapidement à la Veterans Health Administration des États-Unis Poursuite de la mise au point de thérapies avec interface cerveau-ordinateur pour les lésions médu...

 PRESS RELEASE

Nuwellis Announces Pricing of $2.7 Million Public Offering

Nuwellis Announces Pricing of $2.7 Million Public Offering MINNEAPOLIS, April 26, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced the pricing of a public offering of 11,250,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 16,875,000 shares of its common stock at a combined public offering price $0.24 per share (or pre-funded warrant in lieu thereof) and associated warrant. E...

 PRESS RELEASE

Vilkyskiu pienine AB annual information for the year 2023

Vilkyskiu pienine AB annual information for the year 2023 Vilkyskiu pienine AB introduce financial statement for the year 2023  Vilkyskiu pienine AB approved by the Ordinary General Meeting of the Shareholders. The Company informs that the Ex-Date, since which Vilkyskiu pienine AB shares (VLP1L, ISIN kodas LT0000127508) bought via stock exchange with settlement cycle T+2 do not provide the right to dividends for year 2023, is 10 May 2024.           Vilija Milaseviciute          Economics and Finance Director          Phone: Attachment ...

 PRESS RELEASE

Wrap Technologies Announces Exciting New Distributor Agreement with Ko...

Wrap Technologies Announces Exciting New Distributor Agreement with Kokusai Security MIAMI, April 26, 2024 (GLOBE NEWSWIRE) --  Wrap Technologies, Inc. (NASDAQ: WRAP), a global leader in innovative public safety technologies, is proud to announce a strategic distribution partnership with Kokusai Security Service, a leading provider of security solutions in the Asia-Pacific region. This partnership marks a significant milestone for both companies, as they join forces to bring cutting-edge public safety solutions to law enforcement agencies and security professionals across the region. Und...

 PRESS RELEASE

Decisions made by Ordinary General Meeting of Shareholders of ŽEMAITIJ...

Decisions made by Ordinary General Meeting of Shareholders of ŽEMAITIJOS PIENAS, AB The Ordinary General Meeting of Shareholders of ŽEMAITIJOS PIENAS, AB (hereinafter - the Company), which took place on 26 April 2024, heard the auditors' report, as well as consolidated annual report for 2023 and other documents submitted to the Meeting of Shareholders and made decisions on relevant issues. Decisions and other documents are attached to this notice. Arnas MatuzasHead of Legal E-mail:   Attachments ...

 PRESS RELEASE

Decisions taken at the Ordinary General Meeting of the Shareholders, h...

Decisions taken at the Ordinary General Meeting of the Shareholders, held on 26 April 2024 The following decisions were taken at the Ordinary General Meeting of Shareholders of Vilkyskiu pienine AB which was held on the 26 April 2024: Item 1 of the Agenda: Regarding Company's Consolidated annual report for 2023. Heard. Item 2 of the Agenda: Regarding independent auditor‘s conclusion on the Company’s consolidated and separated financial Statements for 2023. Heard. Item 3 of the Agenda: Regarding comments and proposals of Company's Supervisory Board. Comments and propo...

 PRESS RELEASE

The arbitral tribunal has confirmed GF’s redemption right over the min...

The arbitral tribunal has confirmed GF’s redemption right over the minority shares in Uponor and trading in Uponor’s shares has been suspended Uponor Corporation, Stock Exchange Release, April 26, 2024, 4.15 p.m. EET The arbitral tribunal has confirmed GF’s redemption right over the minority shares in Uponor and trading in Uponor’s shares has been suspended The arbitral tribunal appointed by the Redemption Committee of the Finland Chamber of Commerce in connection with the redemption proceedings concerning the minority shares in Uponor Corporation (“Uponor”) has in its interim award c...

 PRESS RELEASE

HWH International Inc. enters into a joint venture to build its travel...

HWH International Inc. enters into a joint venture to build its travel business in Asia Bethesda, MD, April 26, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH”) (Nasdaq: HWH) announced today that it has entered into a joint venture through its subsidiary Health Wealth Happiness Pte Ltd. (“HWHPL”), with Mr. Chen Ziping (“Mr. Chen”), an experienced entrepreneur in the travel industry, and Mr. Chan Heng Fai Ambrose, HWH’s Executive Chairman (“Mr. Chan”). This new joint venture is part of HWH’s strategy of building its travel business in Asia. The joint venture company (referred to he...

 PRESS RELEASE

SOLOWIN HOLDINGS Strengthens Partnership with OSL to Facilitate Hong K...

SOLOWIN HOLDINGS Strengthens Partnership with OSL to Facilitate Hong Kong’s Innovative Spot Virtual Asset ETFs with In-Kind Subscription and Redemption HONG KONG, April 26, 2024 (GLOBE NEWSWIRE) -- SOLOWIN HOLDINGS (Nasdaq: SWIN) ("SOLOWIN" or the "Company"), a securities brokerage company that offers comprehensive financial services primarily to Chinese investors, today announced that the Company, through its subsidiary, Solomon JFZ (Asia) Holdings Limited (“Solomon”), strengthened the partnership with OSL Digital Securities (“OSL”), the digital asset platform of OSL Group (863.HK) – Hon...

 PRESS RELEASE

EQS-News: Logwin AG: Bundeszentralamt stellt Einlagenrückgewähr für Au...

EQS-News: Logwin AG / Schlagwort(e): Dividende Logwin AG: Bundeszentralamt stellt Einlagenrückgewähr für Ausschüttung 2023 an deutsche Anleger fest (News mit Zusatzmaterial) 26.04.2024 / 15:07 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Grevenmacher (Luxemburg) – Die Logwin AG hatte im Oktober 2023 beim deutschen Bundeszentralamt für Steuern einen Antrag nach § 27 Abs. 8 Körperschaftsteuergesetz (Antrag auf Feststellung einer sogenannten Einlagenrückgewähr) für die Ausschüttung 2023 gestellt. Das Bundeszentralamt für Steuern hat nu...

 PRESS RELEASE

EQS-News: Logwin AG: Federal Central Office establishes retribution of...

EQS-News: Logwin AG / Key word(s): Dividend Logwin AG: Federal Central Office establishes retribution of additional capital contribution for 2023 distribution to German investors (news with additional features) 26.04.2024 / 15:07 CET/CEST The issuer is solely responsible for the content of this announcement. Grevenmacher (Luxembourg) - In October 2023, Logwin AG submitted an application to the German Federal Central Tax Office in accordance with Section 27 (8) of the German Corporate Income Tax Act (application for the qualification of a so-called retribution of additional...

 PRESS RELEASE

FEMSA Announces First Quarter 2024 Results

FEMSA Announces First Quarter 2024 Results MONTERREY, Mexico, April 26, 2024 (GLOBE NEWSWIRE) -- Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) announced today its operational and financial results for the first quarter of 2024. FEMSA: Total Consolidated Revenues grew 11.3% compared to 1Q23.FEMSA Retail1: Proximity Americas total Revenues increased 15.1% versus 1Q23.DIGITAL: Spin by OXXO had 7.4 million active users2 while Spin Premia had 21.7 million active loyalty users3 and an average tender3 of 35.1%.COCA...

 PRESS RELEASE

Resolutions to the Annual Shareholders’ Meeting of the JSC ‘Siguldas c...

Resolutions to the Annual Shareholders’ Meeting of the JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ on 26 April 2024 To approve the reports of the company’s management board and the supervisory board on the annual report for the year 2023.To approve the annual report for the year 2023, including the corporate governance report and the remuneration report for members of the management board and the supervisory board, prepared as separate components of the annual report.To leave the profit of the reporting year 65 434.57 euro undistributed. To pay out the retained earnings of 2...

 PRESS RELEASE

AS “Siguldas ciltslietu un mākslīgās apsēklošanas stacija” kārtējās ak...

AS “Siguldas ciltslietu un mākslīgās apsēklošanas stacija” kārtējās akcionāru sapulces 2024. gada 26. aprīlī lēmumi Apstiprināt akciju sabiedrības valdes un padomes ziņojumus par 2023. gada pārskatu.Apstiprināt gada pārskatu par 2023. gadu, t. sk. korporatīvās pārvaldības ziņojumu un valdes un padomes atalgojuma ziņojumu, kas sagatavoti kā atsevišķas gada pārskata sastāvdaļas.Pārskata gada peļņu 65 434,57 EUR atstāt nesadalītu. Izmaksāt no iepriekšējo gadu nesadalītās peļņas, kura uzrādīta bilancē 2017. gada 31. decembrī, dividendēs 21 122,00 eiro, kas ir 0,05 eiro par vienu akciju.  Noteik...

Gamuda Berhad: 2 directors

Two Directors at Gamuda Berhad sold after exercising options/sold 44,354 shares at between 5.258MYR and 5.269MYR. The significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the com...

Basilea Pharmaceutica AG: 1 director

A director at Basilea Pharmaceutica AG sold 2,514 shares at 41.008CHF and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

Telia Company AB: 3 directors

Two Directors at Telia Company AB bought 20,134 shares at between 24.922SEK and 25.590SEK. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...

JDC Group AG: 1 director

A director at JDC Group AG bought 3,000 shares at 21.867EUR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

 PRESS RELEASE

UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Assoc...

UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the Company will present on its innovative modifier gene therapy platform, including OCU400 for the treatment of retinitis pigmentosa (Phase 3 LiMeliGhT clinical trial), OCU410 for the treatment of geographic ...

 PRESS RELEASE

INNOVATE Corp. to Report First Quarter 2024 Results on May 7th

INNOVATE Corp. to Report First Quarter 2024 Results on May 7th NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the first quarter 2024 on Tuesday, May 7, 2024, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet a...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch